Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension

Published:2016-10 Issue:1 Volume:512 Page:305-313
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Wang Zimeng,Cuddigan Julie L.,Gupta Sweta K.,Meenach Samantha A.^ORCID

Funder

National Institute of General Medical Sciences of the National Institutes of Health

National Science Foundation EPSCoR Cooperative Agreement

National Science Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference56 articles.

1. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats;Arima;J. Pharm. Sci.,2001

2. Acetal-Derivatized dextran: an acid-responsive biodegradable material for therapeutic applications;Bachelder;J. Am. Chem. Soc.,2008

3. Targeted treatments for pulmonary arterial hypertension: interpreting outcomes by network meta-analysis;Badiani;Heart Lung Circ.,2016

4. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles;Bootz;Eur. J. Pharm. Biopharm.,2004

5. Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy;Broaders;Proc. Natl. Acad. Sci.,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

2. Exploring the therapeutic potential of naturally occurring piceatannol in non‐communicable diseases;BioFactors;2023-09-13

3. Pulmonary Fibrosis: Unveiling the Pathogenesis, Exploring Therapeutic Targets, and Advancements in Drug Delivery Strategies;AAPS PharmSciTech;2023-07-13

4. Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension;Drug Discovery Today;2023-06

5. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport;Chemical Society Reviews;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3